These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 11911195)
1. Potential insulinominetic agents of zinc(II) complexes with picolinamide derivatives: preparations of complexes, in vitro and in vivo studies. Ueda E; Yoshikawa Y; Ishino Y; Sakurai H; Kojima Y Chem Pharm Bull (Tokyo); 2002 Mar; 50(3):337-40. PubMed ID: 11911195 [TBL] [Abstract][Full Text] [Related]
2. New insulinomimetic zinc(II) complexes of alpha-amino acids and their derivatives with Zn(N2O2) coordination mode. Yoshikawa Y; Ueda E; Suzuki Y; Yanagihara N; Sakurai H; Kojima Y Chem Pharm Bull (Tokyo); 2001 May; 49(5):652-4. PubMed ID: 11383627 [TBL] [Abstract][Full Text] [Related]
3. A new insulin-mimetic bis(allixinato)zinc(II) complex: structure-activity relationship of zinc(II) complexes. Adachi Y; Yoshida J; Kodera Y; Kato A; Yoshikawa Y; Kojima Y; Sakurai H J Biol Inorg Chem; 2004 Oct; 9(7):885-93. PubMed ID: 15378407 [TBL] [Abstract][Full Text] [Related]
4. Bis(6-ethylpicolinato)oxovanadium(IV) complex with normoglycemic activity in KK-A(y) mice. Sasagawa T; Yoshikawa Y; Kawabe K; Sakurai H; Kojima Y J Inorg Biochem; 2002 Jan; 88(1):108-12. PubMed ID: 11750032 [TBL] [Abstract][Full Text] [Related]
5. Development of new insulinomimetic zinc(II) picolinate complexes with a Zn(N2O2) coordination mode: structure characterization, in vitro, and in vivo studies. Yoshikawa Y; Ueda E; Kawabe K; Miyake H; Takino T; Sakurai H; Kojima Y J Biol Inorg Chem; 2002 Jan; 7(1-2):68-73. PubMed ID: 11862542 [TBL] [Abstract][Full Text] [Related]
6. Insulinomimetic bis(maltolato)zinc(II) complex: blood glucose normalizing effect in KK-A(y) mice with type 2 diabetes mellitus. Yoshikawa Y; Ueda E; Miyake H; Sakurai H; Kojima Y Biochem Biophys Res Commun; 2001 Mar; 281(5):1190-3. PubMed ID: 11243860 [TBL] [Abstract][Full Text] [Related]
7. Antidiabetic zinc(II)-N-acetyl-L-cysteine complex: evaluations of in vitro insulinomimetic and in vivo blood glucose-lowering activities. Adachi Y; Yoshikawa Y; Sakurai H Biofactors; 2007; 29(4):213-23. PubMed ID: 18057552 [TBL] [Abstract][Full Text] [Related]
8. Orally active and long-term acting insulin-mimetic vanadyl complex:bis(picolinato)oxovanadium (IV). Sakurai H; Fujii K; Watanabe H; Tamura H Biochem Biophys Res Commun; 1995 Sep; 214(3):1095-101. PubMed ID: 7575515 [TBL] [Abstract][Full Text] [Related]
9. Insulinomimetic Zn(II) complexes as evaluated by both glucose-uptake activity and inhibition of free fatty acids release in isolated rat adipocytes. Nishide M; Yoshikawa Y; Yoshikawa EU; Matsumoto K; Sakurai H; Kajiwara NM Chem Pharm Bull (Tokyo); 2008 Aug; 56(8):1181-3. PubMed ID: 18670123 [TBL] [Abstract][Full Text] [Related]
10. Insulin-mimetic vanadyl(IV) complexes as evaluated by both glucose-uptake and inhibition of free fatty acids (FFA)-release in isolated rat adipocytes. Adachi Y; Sakurai H Chem Pharm Bull (Tokyo); 2004 Apr; 52(4):428-33. PubMed ID: 15056957 [TBL] [Abstract][Full Text] [Related]
11. Structure-dependent metallokinetics of antidiabetic vanadyl-picolinate complexes in rats: studies on solution structure, insulinomimetic activity, and metallokinetics. Yasui H; Tamura A; Takino T; Sakurai H J Inorg Biochem; 2002 Jul; 91(1):327-38. PubMed ID: 12121792 [TBL] [Abstract][Full Text] [Related]
12. The action mechanism of zinc(II) complexes with insulinomimetic activity in rat adipocytes. Yoshikawa Y; Ueda E; Kojima Y; Sakurai H Life Sci; 2004 Jun; 75(6):741-51. PubMed ID: 15172182 [TBL] [Abstract][Full Text] [Related]
13. Syntheses of vanadyl and zinc(II) complexes of 1-hydroxy-4,5,6-substituted 2(1H)-pyrimidinones and their insulin-mimetic activities. Yamaguchi M; Wakasugi K; Saito R; Adachi Y; Yoshikawa Y; Sakurai H; Katoh A J Inorg Biochem; 2006 Feb; 100(2):260-9. PubMed ID: 16387366 [TBL] [Abstract][Full Text] [Related]
14. Blood glucose lowering and toxicological effects of zinc (II) complexes with maltol, threonine, and picolinic acid. Kojima Y; Yoshikawa Y; Ueda E; Kondo M; Takahashi S; Matsukura T; Sakurai H; Hiroi T; Imaoka S; Funae Y Res Commun Mol Pathol Pharmacol; 2002; 112(1-4):91-104. PubMed ID: 15080500 [TBL] [Abstract][Full Text] [Related]
15. The pharmacology of the insulinomimetic effect of zinc complexes. Sakurai H; Adachi Y Biometals; 2005 Aug; 18(4):319-23. PubMed ID: 16158223 [TBL] [Abstract][Full Text] [Related]
16. A family of insulinomimetic zinc(II) complexes of amino ligands with Zn(Nn) (n=3 and 4) coordination modes. Yoshikawa Y; Kondo M; Sakurai H; Kojima Y J Inorg Biochem; 2005 Jul; 99(7):1497-503. PubMed ID: 15921760 [TBL] [Abstract][Full Text] [Related]
17. Synthesis and insulinomimetic activities of novel mono- and tetranuclear oxovanadium(IV) complexes with 3-hydroxypyridine-2-carboxylic acid. Nakai M; Obata M; Sekiguchi F; Kato M; Shiro M; Ichimura A; Kinoshita I; Mikuriya M; Inohara T; Kawabe K; Sakurai H; Orvig C; Yano S J Inorg Biochem; 2004 Jan; 98(1):105-12. PubMed ID: 14659639 [TBL] [Abstract][Full Text] [Related]
18. Antidiabetic copper(II)-picolinate: impact of the first transition metal in the metallopicolinate complexes. Yasumatsu N; Yoshikawa Y; Adachi Y; Sakurai H Bioorg Med Chem; 2007 Jul; 15(14):4917-22. PubMed ID: 17531495 [TBL] [Abstract][Full Text] [Related]
19. Insulinomimetic zinc(II) complexes with natural products: in vitro evaluation and blood glucose lowering effect in KK-Ay mice with type 2 diabetes mellitus. Kojima Y; Yoshikawa Y; Ueda E; Ueda R; Yamamoto S; Kumekawa K; Yanagihara N; Sakurai H Chem Pharm Bull (Tokyo); 2003 Aug; 51(8):1006-8. PubMed ID: 12913247 [TBL] [Abstract][Full Text] [Related]
20. Mechanism on insulin-like action of vanadyl sulfate: studies on interaction between rat adipocytes and vanadium compounds. Nakai M; Watanabe H; Fujiwara C; Kakegawa H; Satoh T; Takada J; Matsushita R; Sakurai H Biol Pharm Bull; 1995 May; 18(5):719-25. PubMed ID: 7492989 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]